Raymond James Keeps Their Buy Rating on Bath & Body Works (BBWI)
Raymond James analyst Olivia Tong reiterated a Buy rating on Bath & Body Works (BBWI – Research Report) today and set a price target of $37.00. The company’s shares closed yesterday at $28.58.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Tong is a 4-star analyst with an average return of 7.3% and a 54.05% success rate. Tong covers the Consumer Cyclical sector, focusing on stocks such as Ulta Beauty, e.l.f. Beauty, and Bath & Body Works.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Bath & Body Works with a $41.57 average price target, a 45.45% upside from current levels. In a report released today, Morgan Stanley also maintained a Buy rating on the stock with a $41.00 price target.
Based on Bath & Body Works’ latest earnings release for the quarter ending February 1, the company reported a quarterly revenue of $2.79 billion and a net profit of $453 million. In comparison, last year the company earned a revenue of $2.91 billion and had a net profit of $579 million
Read More on BBWI:
Disclaimer & DisclosureReport an Issue
- Bath & Body Works price target lowered to $41 from $43 at Morgan Stanley
- Positive Outlook for Bath & Body Works Amid Market Positioning and Growth Potential
- Bath & Body Works price target lowered to $40 from $45 at BofA
- Positive Outlook for Bath & Body Works Driven by Strategic Leadership and Innovation
- Buy Rating for Bath & Body Works: Promising Sales Growth and Strategic Innovation Amid Tariff Challenges
